The therapeutic effect of stroke is hampered by the lack of neuroprotective drugs against ischemic insults beyond the acute phase. Carnitine plays important roles in mitochondrial metabolism and in modulating the ratio of coenzyme A (CoA)/acyl-CoA. Here, we investigate the neuroprotective effects of l-carnitine (LC) and Acetyl-l-carnitine (ALC) pre-treatment on ischemic insults under the same experimental conditions. We used a transient middle cerebral artery occlusion (MCAO) model to evaluate the protective roles of LC and ALC in acute focal cerebral ischemia in vivo and to understand the possible mechanisms using model of PC12 cell cultures in vitro. Results showed that ALC, but not LC, decreased infarction size in SD rats after MCAO in vivo. However, both LC and ALC pretreatment reduced oxygen-glucose deprivation (OGD)-induced cell injury and decreased OGD-induced cell apoptosis and death in vitro; at the same time, both of them increased the activities of super oxide dismutase (SOD) and ATPase, and decreased the concentration of malondialdehyde (MDA) in vitro. Thus, our findings suggested that LC and ALC pre-treatment are highly effective in the prevention of neuronal cell against ischemic injury in vitro, however, only ALC has the protective effect on neuronal cell injury after ischemia in vivo.
References
[1]
Murray, C.J.; Lopez, A.D. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997, 349, 1269–1276.
[2]
Deshpande, J.K.; Siesjo, B.K.; Wieloch, T. Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia. J. Cereb. Blood Flow Metab 1987, 7, 89–95.
[3]
MacManus, J.P.; Buchan, A.M.; Hill, I.E.; Rasquinha, I.; Preston, E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett 1993, 164, 89–92.
[4]
Leist, M.; Jaattela, M. Four deaths and a funeral: From caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol 2001, 2, 589–598.
[5]
Picconi, B.; Barone, I.; Pisani, A.; Nicolai, R.; Benatti, P.; Bernardi, G.; Calvani, M.; Calabresi, P. Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine. Neuropharmacology 2006, 50, 917–923.
[6]
Zivin, J.A. Neuroprotective therapies in stroke. Drugs 1997, 54, 83–88. discussion 88–89.
[7]
Flanagan, J.L.; Simmons, P.A.; Vehige, J.; Willcox, M.D.; Garrett, Q. Role of carnitine in disease. Nutr. Metab. (Lond.) 2010, 7, 30–43.
[8]
Virmani, A.; Binienda, Z. Role of carnitine esters in brain neuropathology. Mol. Aspects Med 2004, 25, 533–549.
[9]
Wainwright, M.S.; Kohli, R.; Whitington, P.F.; Chace, D.H. Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats. Stroke 2006, 37, 524–530.
[10]
Zanelli, S.A.; Solenski, N.J.; Rosenthal, R.E.; Fiskum, G. Mechanisms of ischemic neuroprotection by acetyl-l-carnitine. Ann. N.Y. Acad. Sci 2005, 1053, 153–161.
[11]
Slivka, A.; Silbersweig, D.; Pulsinelli, W. Carnitine treatment for stroke in rats. Stroke 1990, 21, 808–811.
[12]
Turkyilmaz, C.; Turkyilmaz, Z.; Onal, E.; Atalay, Y.; Soylemezoglu, F.; Celasun, B. l-Carnitine pre-treatment reduces apoptotic cell death in seven-day-old rats hypoxia ischemia. Restor. Neurol. Neurosci 2010, 28, 817–824.
[13]
Jalal, F.Y.; Bohlke, M.; Maher, T.J. Acetyl-l-carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats. Ann. N.Y. Acad. Sci 2010, 1199, 95–104.
[14]
Sitprija, V. Altered fluid, electrolyte and mineral status in tropical disease, with an emphasis on malaria and leptospirosis. Nat. Clin. Pract. Nephrol 2008, 4, 91–101.
[15]
Llansola, M.; Felipo, V. Carnitine prevents NMDA receptor-mediated activation of MAP-kinase and phosphorylation of microtubule-associated protein 2 in cerebellar neurons in culture. Brain Res 2002, 947, 50–56.
[16]
Breitkreutz, R.; Babylon, A.; Hack, V.; Schuster, K.; Tokus, M.; Bohles, H.; Hagmuller, E.; Edler, L.; Holm, E.; Droge, W. Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases. Br. J. Cancer 2000, 82, 399–403.
[17]
Ferrari-Toninelli, G.; Maccarinelli, G.; Uberti, D.; Buerger, E.; Memo, M. Mitochondria-targeted antioxidant effects of S(？) and R(+) pramipexole. BMC Pharmacol 2010, 10, doi:10.1186/1471-2210-10-2..
[18]
Garrett, Q.; Xu, S.; Simmons, P.A.; Vehige, J.; Flanagan, J.L.; Willcox, M.D. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium. Invest. Ophthalmol. Vis. Sci 2008, 49, 4844–4849.
[19]
Inazu, M.; Takeda, H.; Maehara, K.; Miyashita, K.; Tomoda, A.; Matsumiya, T. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. J. Neurochem 2006, 97, 424–434.
[20]
Muneer, P.M.A.; Alikunju, S.; Szlachetka, A.M.; Mercer, A.J.; Haorah, J. Ethanol impairs glucose uptake by human astrocytes and neurons: Protective effects of acetyl-l-carnitine. Int. J. Physiol. Pathophysiol. Pharmacol 2011, 3, 48–56.
[21]
Scafidi, S.; Fiskum, G.; Lindauer, S.L.; Bamford, P.; Shi, D.; Hopkins, I.; McKenna, M.C. Metabolism of acetyl-l-carnitine for energy and neurotransmitter synthesis in the immature rat brain. J. Neurochem 2010, 114, 820–831.
[22]
Singh, G.; Siddiqui, M.A.; Khanna, V.K.; Kashyap, M.P.; Yadav, S.; Gupta, Y.K.; Pant, K.K.; Pant, A.B. Oxygen glucose deprivation model of cerebral stroke in PC-12 cells: Glucose as a limiting factor. Toxicol. Mech. Methods 2009, 19, 154–160.
[23]
Hota, K.B.; Hota, S.K.; Chaurasia, O.P.; Singh, S.B. Acetyl-l-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis. Hippocampus 2011, doi:10.1002/hipo.20934..
[24]
Yuan, J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis 2009, 14, 469–477.
[25]
Qi, J.; Hong, Z.Y.; Xin, H.; Zhu, Y.Z. Neuroprotective effects of leonurine on ischemia/reperfusion-induced mitochondrial dysfunctions in rat cerebral cortex. Biol. Pharm. Bull 2010, 33, 1958–1964.
[26]
Siktar, E.; Ekinci, D.; Beydemir, S.; Gulcin, I.; Gunay, M. Protective role of l-carnitine supplementation against exhaustive exercise induced oxidative stress in rats. Eur. J. Pharmacol 2011, 668, 407–413.
[27]
Kim, W.; Kim, D.W.; Yoo, D.Y.; Chung, J.Y.; Hwang, I.K.; Won, M.H.; Choi, S.Y.; Jeon, S.W.; Jeong, J.H.; Hwang, H.S.; et al. Neuroprotective effects of PEP-1-Cu, Zn-SOD against ischemic neuronal damage in the rabbit spinal cord. Neurochem. Res 2011, 37, 307–313.
[28]
Haorah, J.; Floreani, N.A.; Knipe, B.; Persidsky, Y. Stabilization of superoxide dismutase by acetyl-l-carnitine in human brain endothelium during alcohol exposure: Novel protective approach. Free Radic. Biol. Med 2011, 51, 1601–1609.
[29]
Derin, N.; Izgut-Uysal, V.N.; Agac, A.; Aliciguzel, Y.; Demir, N. l-Carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. J. Physiol. Pharmacol 2004, 55, 595–606.
[30]
Shuaib, A.; Waqaar, T.; Wishart, T.; Kanthan, R.; Howlett, W. Acetyl-l-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult. Neurochem. Res 1995, 20, 1021–1025.
[31]
Lin, T.N.; He, Y.Y.; Wu, G.; Khan, M.; Hsu, C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993, 24, 117–121.
[32]
, version 16.0; IBM Corporation: Armonk, NY, USA, 2008.
